Stockreport

Olema Oncology Announces Departure of Chief Operating and Financial Officer

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company f [Read more]